court-watch
lawsuit
Pomerantz LLP Moves to File Class Action Lawsuit Against Nektar Therapeutics ...
updateUpdated 1 day ago
|
|
Filed
Advertisement
description
Case Summary
Pomerantz LLP has initiated a class action lawsuit against Nektar Therapeutics, targeting investors who acquired securities during a specific period. The lawsuit seeks to hold Nektar accountable for alleged misrepresentations or omissions in financial disclosures, aiming to protect investors and ensure transparency in the pharmaceutical industry.
Stage
Active litigation
Timeline
1 event
Coverage
1 article
Sources
1
Key Issues
- • Class action lawsuit against Nektar Therapeutics
- • Investors with securities purchased during the Class Period
- • Allegations of misrepresentations in financial disclosures
- • Potential settlement or trial outcomes
- • Impact on pharmaceutical industry transparency
update What Changed This Week
1 event
1 article
newspaper
gdelt
1 day, 7 hours ago
Pomerantz LLP Moves to File Class Action Lawsuit Against Nektar Therapeutics ...
info
Other
1 day, 8 hours ago
Pomerantz LLP Moves to File Class Action Lawsuit Against Nektar Therapeutics ...
Advertisement
Case Timeline
1 event
info
Other
April 16, 2026
Pomerantz LLP Moves to File Class Action Lawsuit Against Nektar Therapeutics ...
Pomerantz LLP has filed a motion to initiate a class action lawsuit against Nektar Therapeutics, targeting investors who acquired the company's securities during a specific period. Investors have until May 5, 2026, to request to become the lead plaintiff in this potential class action lawsuit.
Advertisement
show_chart
Coverage Timeline
newspaper
1 article